Mobile-health Network Solutions vs OrangeKloud Technology
MNDR and ORKT side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MNDR and ORKT compare
OrangeKloud Technology grew revenue faster over the last twelve months (40.6% versus 1.2% for Mobile-health Network Solutions).
Mobile-health Network Solutions keeps more of each dollar of sales as profit, with a net margin of −41.2% compared with −78.7% at OrangeKloud Technology.
Mobile-health Network Solutions scores higher on the StockData Score (7 against 3 for OrangeKloud Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MNDR | ORKT |
|---|---|---|
| Size and price | ||
| Share price | $0.945 | $0.974 |
| Change, 1 year | −91.6% | −19.5% |
| Beta (5Y) | −0.64 | 1.23 |
| Employees | 69 | 64 |
| StockData Score | ||
| Total score | 7 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 1.2% | 40.6% (better) |
| Profitability | ||
| Gross margin | 21.2% | 44.2% (better) |
| Operating margin | – | −131% |
| Net margin | −41.2% (better) | −78.7% |
| FCF margin | −19.7% (better) | −87.0% |
| Return on equity | −51.0% | −40.5% (better) |
| Return on invested capital | – | −108% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −315.7× |
| Current ratio | 3.97 (better) | 2.43 |
| Piotroski F-score | 6 (better) | 3 |
| Ownership | ||
| Held by institutions | 0.00% | – |
| Held by insiders | 64.7% | 66.7% |
| Short interest, % of float | 16.3% | – |
Go deeper
- MNDR stock overview
- MNDR income statement
- MNDR valuation and score
- ORKT stock overview
- ORKT income statement
- ORKT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.